Homoeopathic Treatment of Mild Cases of COVID-19 on Home Isolation: A Retrospective Observational Study

This study was conducted to evaluate the effect of individualised homoeopathic medicine on mild cases of COVID-19 under home isolation. A retrospective, single-arm, non-randomised, open-label, observational trial was conducted on 185 laboratory confirmed mild cases of COVID-19 at Nehru Homoeopathic Medical College and Hospital, Delhi, during September to December 2020. Complete symptom resolution days was the primary outcome (from baseline to total zero symptom score); Each COVID-19 symptom and sign was assessed on a scale of 0 to 3 (0–absent, 1–mild, 2–moderate, 3–severe) to assess the symptom incidence and severity both at baseline and during daily follow-up for 14 days after enrolment to assess the effect of individualised homoeopathic medicines as the secondary outcomes. Intention-to-treat sample (n = 185) was analysed in SPSS IBM version 20. Of all the patients (n = 185), 165 (90%) successfully completed the follow-up period. The mean (interquartile range [IQR]) age was 35 (26–45) years; the male: female ratio was 11:9.2. Fever (56%), cough (54%), fatigue (45%) and sore throat (36%) were the most common symptoms reported. Median (IQR) time for resolution of symptoms was 4 (3–8) days. Sixty-eight per cent patients recovered within 6 days and rest within 7 to 14 days. The most prescribed medicines were Bryonia alba (30%), Arsenicum album (25%) and Pulsatilla nigricans (12%) accounting for 67% of the total medicines. This study, though preliminary, revea...
Source: Homoeopathic Links - Category: Complementary Medicine Authors: Tags: Original Article Source Type: research